Omgeo acquires Allustra for collateral management

"When we looked at the evolution of the buy side over the past five years, we saw that there was a gap in automation around collateral and how firms administer their OTC derivatives portfolios," explains Tim Lind, managing director of strategic planning at Omgeo.

According to Lind, it was preferable to make an acquisition rather than build collateral management functionality because of the speed at which the market is evolving.

Allustra was selected as it was "more suited to a buy-side impleme

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: